Literature DB >> 19031077

Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on "olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders".

Laura Parkkinen1, Laura Silveira-Moriyama, Janice L Holton, Andrew J Lees, Tamas Revesz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19031077     DOI： 10.1007/s00401-008-0462-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  7 in total

1.  Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment.

Authors:  Cécilia Tremblay; Geidy E Serrano; Anthony J Intorcia; Monica R Mariner; Lucia I Sue; Richard A Arce; Alireza Atri; Charles H Adler; Christine M Belden; Holly A Shill; Erika Driver-Dunckley; Shyamal H Mehta; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2022-07-19       Impact factor: 3.148

2.  Biopsable neural tissues: toward new biomarkers for Parkinson's disease?

Authors:  Thibaud Lebouvier; Maddalena Tasselli; Sébastien Paillusson; Hélène Pouclet; Michel Neunlist; Pascal Derkinderen
Journal:  Front Psychiatry       Date:  2010-09-03       Impact factor: 4.157

3.  Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease.

Authors:  Isidro Ferrer
Journal:  Parkinsons Dis       Date:  2011-02-17

4.  Brain biopsy in neurologic decline of unknown etiology.

Authors:  Shino Magaki; Tracie Gardner; Negar Khanlou; William H Yong; Noriko Salamon; Harry V Vinters
Journal:  Hum Pathol       Date:  2014-12-31       Impact factor: 3.466

Review 5.  The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases.

Authors:  Isabel Ubeda-Bañon; Daniel Saiz-Sanchez; Alicia Flores-Cuadrado; Ernesto Rioja-Corroto; Melania Gonzalez-Rodriguez; Sandra Villar-Conde; Veronica Astillero-Lopez; Juan Pablo Cabello-de la Rosa; Maria Jose Gallardo-Alcañiz; Julia Vaamonde-Gamo; Fernanda Relea-Calatayud; Lucia Gonzalez-Lopez; Alicia Mohedano-Moriano; Alberto Rabano; Alino Martinez-Marcos
Journal:  Transl Neurodegener       Date:  2020-06-03       Impact factor: 8.014

Review 6.  α-Synuclein and mitochondrial dysfunction in Parkinson's disease.

Authors:  Stephen Mullin; Anthony Schapira
Journal:  Mol Neurobiol       Date:  2013-01-30       Impact factor: 5.590

Review 7.  The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.

Authors:  Paul C Donaghy; Ian G McKeith
Journal:  Alzheimers Res Ther       Date:  2014-07-21       Impact factor: 6.982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.